secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-045035
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $150K convertible note to One44 Capital at 10% interest, 60% conversion discount
--------------------------------------------------------------------------------

- Principal $150K; purchase price $135K (15% OID); 10% interest; maturity Dec 8, 2024.
- Convertible at 60% of lowest trading price over prior 15 days; subject to 4.99% beneficial ownership cap.
- Issued under Regulation D private placement; net proceeds for working capital.
- Prepayment option: 115% within 60 days, 130% 61-120 days, 140% 121-180 days; none after 180 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223045035/0001493152-23-045035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223045035/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer